Insider Shareholders with Direct Ownership of Quest Diagnostics Inc (DGX)
This section provides a comprehensive overview of the insiders with direct ownership of Quest Diagnostics Inc (DGX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
QUEST DIAGNOSTICS INC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Stephen H Rusckowski
Director |
1,139,910 | 988,060 | 389,597 $53.4 Million | 30 |
Mar 06, 2023
Reduced 9.02%
|
|
J. E. Davis
CEO and President |
134,146 | 46,264 | 125,968 $17.3 Million | 20 |
Feb 28, 2024
Reduced 1.41%
|
|
Mark Guinan
Executive Vice President & CFO |
127,774 | 102,372 | 98,981 $13.6 Million | 11 |
Mar 07, 2022
Reduced 9.57%
|
|
Catherine T. Doherty
EVP, Regional Businesses |
137,663 | 137,662 | 68,412 $9.38 Million | 31 |
Feb 29, 2024
Reduced 1.71%
|
|
Manner Carrie Eglinton
SVP, Advanced Diagnostics |
46,014 | 20,357 | 48,391 $6.63 Million | 10 |
Mar 07, 2022
Reduced 14.11%
|
|
Michael E Prevoznik
SVP & General Counsel |
212,504 | 213,925 | 38,478 $5.27 Million | 37 |
Aug 29, 2024
Reduced 45.83%
|
|
Michael J Deppe
SVP, Corp. Controller & CAO |
39,406 | 29,900 | 34,930 $4.79 Million | 25 |
Feb 28, 2024
Reduced 0.16%
|
|
Manuel O. Mendez
SVP & Chief Commercial Officer |
4,926 | 5,871 | 29,045 $3.98 Million | 2 |
Feb 17, 2021
Added 14.5%
|
|
Gary M Pfeiffer
Director |
5,506 | 0 | 28,916 $3.96 Million | 4 |
May 16, 2024
Added 4.88%
|
|
Daniel Stanzione
Director |
0 | 11,223 | 28,349 $3.89 Million | 1 |
Nov 23, 2020
Reduced 7.5%
|
|
Timothy M Ring
Director |
17,531 | 12,025 | 27,798 $3.81 Million | 16 |
May 16, 2024
Added 5.06%
|
|
Timothy L Main
Director |
5,506 | 0 | 25,094 $3.44 Million | 4 |
May 16, 2024
Added 5.58%
|
|
Gail R Wilensky
Director |
22,357 | 18,333 | 20,506 $2.81 Million | 7 |
May 17, 2023
Added 6.26%
|
|
Vicky B Gregg
Director |
6,339 | 2,500 | 18,045 $2.47 Million | 16 |
Oct 21, 2024
Added 0.42%
|
|
Sam Samad
Executive Vice President & CFO |
10,305 | 8,475 | 17,504 $2.4 Million | 10 |
Oct 21, 2024
Added 0.21%
|
|
Patrick Plewman
SVP for Diagnostic Services |
9,738 | 2,688 | 16,258 $2.23 Million | 20 |
Oct 21, 2024
Added 0.37%
|
|
Karthik Kuppusamy
SVP, Clinical Solutions |
8,978 | 7,510 | 9,734 $1.33 Million | 23 |
Oct 28, 2024
Reduced 15.42%
|
|
Denise M Morrison
Director |
5,506 | 0 | 9,490 $1.3 Million | 4 |
May 16, 2024
Added 13.51%
|
|
Wright Lassiter Iii
Director |
5,506 | 0 | 7,709 $1.06 Million | 4 |
May 16, 2024
Added 16.12%
|
|
Helen Torley
Director |
1,363 | 0 | 6,260 $858,183 | 1 |
May 25, 2021
Added 17.88%
|
|
Tracey Doi
Director |
5,048 | 0 | 5,183 $710,537 | 4 |
May 16, 2024
Added 22.24%
|
|
Mark E Delaney
SVP & Chief Commercial Officer |
4,277 | 985 | 5,023 $688,603 | 8 |
Oct 21, 2024
Added 0.08%
|
|
Mark A Gardner
SVP of Molecular Gen & Oncol |
4,169 | 498 | 4,673 $640,621 | 5 |
Sep 24, 2024
Reduced 2.5%
|
|
Luis Diaz
Director |
2,851 | 0 | 2,851 $390,843 | 2 |
May 16, 2024
Added 34.2%
|
|
Robert B Carter
Director |
1,482 | 0 | 1,482 $203,167 | 1 |
May 16, 2024
Added 50.0%
|